Can You Get Pregnant During Perimenopause?

Why Pregnancy Is Still Possible During Perimenopause

Perimenopause does not switch off ovulation on a set schedule. The ovaries continue releasing eggs, just less predictably than they did in your 20s and 30s. A 2018 analysis in Menopause found that women in early perimenopause ovulated in roughly 78% of cycles, while women in late perimenopause still ovulated in approximately 39% of cycles [1]. That second number surprises many people. Nearly four in ten late-perimenopausal cycles still carry a real pregnancy window.

What "Perimenopause" Actually Means Clinically

The STRAW+10 (Stages of Reproductive Aging Workshop) staging system, published in Fertility and Sterility and widely adopted by the American College of Obstetricians and Gynecologists (ACOG), defines the menopausal transition using bleeding pattern changes and serum hormone levels [2]. Early perimenopause begins when cycle length varies by 7 or more days. Late perimenopause is marked by 60 or more days of amenorrhea before the final period arrives.

Neither stage equals infertility. The hormonal chaos of perimenopause, driven by erratic follicle-stimulating hormone (FSH) surges and dropping anti-Mullerian hormone (AMH), still produces intermittent ovulatory events.

The Hormonal Picture Behind Intermittent Ovulation

FSH rises as the ovarian reserve declines, but this rise is not linear. Some cycles, FSH spikes high enough to recruit a follicle that then releases an egg. Other cycles, FSH falls short. Estradiol swings can mimic the LH surge environment, triggering unexpected ovulation even when a woman has gone 45 or 60 days without bleeding. This unpredictability is precisely what makes fertility tracking unreliable during the transition.

AMH, which reflects the remaining egg pool, drops steadily through perimenopause. A 2020 study in Human Reproduction (N=3,200) showed AMH <0.1 ng/mL corresponded to a median time to final menstrual period of about 5 years, but individual variability was wide [3]. Low AMH does not rule out pregnancy.

How Fertility Changes Across the Perimenopausal Transition

Fertility declines gradually, but the decline is not a cliff. At age 40, natural monthly fecundity (the probability of conceiving in a given cycle) is estimated at roughly 5%, compared with about 20% at age 30 [4]. By age 44, that figure drops to roughly 1 to 2%. Small numbers, but not zero.

Early Perimenopause (Late 30s to Mid-40s)

Cycles are still relatively close together, though variability begins. Ovulation occurs in most cycles. Pregnancy rates without contraception remain meaningful, which is why unintended pregnancies in women aged 40 to 44 are more common than many clinicians and patients expect. The CDC's National Survey of Family Growth data show that roughly 42% of pregnancies in women aged 40 to 44 are unintended [5].

Late Perimenopause (Mid to Late 40s)

Cycles become longer and more erratic. Stretches of 60 to 90 days between periods are normal. This can create a false sense of security. A woman who has not bled in three months may assume she is done ovulating. She may not be. Ovulation can still occur at any point during a long follicular phase.

The Post-Period Window That Catches People Off Guard

One particularly confusing scenario: a woman misses several periods, assumes menopause has arrived, stops contraception, and then has a spontaneous ovulation followed by a period, or followed by a pregnancy. This happens because the 12-month amenorrhea rule requires 12 consecutive months, and any bleeding during that window resets the clock entirely.

Risks Associated With Perimenopausal Pregnancy

Pregnancy during perimenopause carries real maternal and fetal risks that differ from those in younger women. Being aware of them helps with decision-making, whether a pregnancy is planned or unintended.

Miscarriage

Chromosomal errors in eggs increase with age. At age 40 to 44, the CDC estimates the miscarriage rate at approximately 34% of recognized pregnancies. At age 45 and older, this rises to roughly 53% [5]. These figures reflect chromosomal aneuploidy in eggs, a consequence of the long meiotic arrest that oocytes undergo across a woman's lifetime.

Ectopic Pregnancy

The ectopic pregnancy rate rises with age, partly because older fallopian tubes may have accumulated subclinical changes over decades. Any positive pregnancy test in a perimenopausal woman warrants prompt transvaginal ultrasound to confirm intrauterine location.

Gestational Diabetes and Hypertensive Disorders

A large population-based cohort study in JAMA Internal Medicine (N=39,117 deliveries to women aged 40 and older) found rates of gestational diabetes of 15.6% and preeclampsia of 9.5%, both substantially higher than in women aged 25 to 29 [6]. These complications are manageable with proper prenatal monitoring, but they require specialist-level care.

Chromosomal Conditions in the Fetus

The risk of trisomy 21 (Down syndrome) at age 40 is approximately 1 in 100 live births, rising to 1 in 30 at age 45, compared with 1 in 1,480 at age 20 [4]. Prenatal genetic counseling and testing (cell-free DNA screening, amniocentesis) are standard of care for perimenopausal pregnancies.

Contraception During Perimenopause: What Works and What to Avoid

Contraception during perimenopause is not one-size-fits-all. The right choice depends on bleeding patterns, cardiovascular risk, bone density, and whether symptom relief from the contraceptive method is a factor.

Combined Oral Contraceptives (Low-Dose)

Low-dose combined oral contraceptives (COCs) containing 20 mcg ethinyl estradiol can suppress ovulation reliably and also reduce hot flashes and regulate irregular bleeding. ACOG Practice Bulletin No. 206 notes that healthy, non-smoking perimenopausal women can use low-dose COCs safely through the menopausal transition [7].

The WHO Medical Eligibility Criteria classifies combined hormonal contraceptives as Category 2 (benefits generally outweigh risks) for women aged 40 and older who do not smoke and have no cardiovascular risk factors, and Category 3 or 4 (risks may outweigh benefits) for women who smoke or have hypertension, migraine with aura, or a personal history of venous thromboembolism [8].

Progestin-Only Methods

The progestin-only pill (norethindrone 0.35 mg daily), the hormonal IUD (levonorgestrel 52 mg, marketed as Mirena), and the progestin implant (etonogestrel 68 mg, marketed as Nexplanon) are all effective and avoid the estrogen-related cardiovascular risks relevant to older women. The levonorgestrel IUD offers the added benefit of reducing heavy perimenopausal bleeding, which affects up to 25% of women in this transition according to data from the SWAN (Study of Women's Health Across the Nation) cohort [9].

Copper IUD

The copper IUD (ParaGard) provides highly effective, hormone-free contraception for up to 10 years. It is a strong option for women who want to avoid any hormonal exposure. Its main downside in perimenopause is that it can worsen already heavy or prolonged periods.

Barrier Methods

Condoms, diaphragms, and cervical caps carry no systemic effects but require consistent use. Their typical-use failure rates (male condom: approximately 13% per year; diaphragm: approximately 17% per year) are worth discussing honestly with patients who may underestimate perimenopausal fertility [10].

What to Avoid: Relying on FSH Alone

A single serum FSH measurement above 30 mIU/mL is sometimes used colloquially as a sign that a woman "can't get pregnant anymore." This interpretation is incorrect. FSH levels fluctuate cycle to cycle during perimenopause. The North American Menopause Society (NAMS) states explicitly in its 2022 Hormone Therapy Position Statement that FSH levels are not a reliable surrogate for cessation of contraceptive need [11]. A woman who tests high FSH one month may ovulate the next.

When Can You Safely Stop Using Contraception?

The clinical rule is straightforward: continue contraception until you have gone 12 consecutive months without any menstrual bleeding. This applies to women who reach natural menopause.

For women using hormonal contraception, that 12-month window is harder to confirm because the method itself may suppress bleeding. Options include:

1. Switching to a non-hormonal method at approximately age 50 to 51 and then tracking for 12 months of amenorrhea.
2. Checking FSH on two separate occasions, at least 6 to 8 weeks apart, while off hormonal contraception. Two FSH readings above 30 mIU/mL in a woman over 50 with amenorrhea may support stopping contraception, though NAMS cautions this is not a definitive cutoff [11].
3. Consulting a gynecologist for individualized guidance, particularly if perimenopausal symptoms (night sweats, vasomotor instability, vaginal dryness) have already prompted discussions about menopausal hormone therapy (MHT).

For women who had surgical menopause (bilateral oophorectomy), contraception is no longer needed after the procedure. For women using GnRH agonists such as leuprolide acetate for conditions like endometriosis, ovarian function may resume after stopping treatment, so contraception should continue unless surgical menopause has been confirmed.

Perimenopausal Pregnancy: Making an Informed Decision

If a perimenopausal woman discovers she is pregnant, she faces decisions that benefit from timely medical input and, for many, genetic counseling. The key steps are:

• Confirm intrauterine location with transvaginal ultrasound as soon as the test is positive.
• Establish care with a maternal-fetal medicine (MFM) specialist given the elevated risk profile.
• Discuss chromosomal screening options, including cell-free DNA (cfDNA) testing starting at 10 weeks and diagnostic amniocentesis if indicated.
• Review any current medications for teratogenic risk. Women on MHT or hormonal contraception should stop immediately if continuing the pregnancy.
• Plan for glucose tolerance testing, blood pressure monitoring, and fetal growth surveillance throughout the pregnancy.

For women who do not wish to continue the pregnancy, mifepristone 200 mg followed by misoprostol 800 mcg (the FDA-approved medication abortion regimen) is effective through 70 days of gestation (10 weeks from last menstrual period) and carries a success rate of approximately 95 to 98% [12]. Procedural options (aspiration, dilation and evacuation) are also available depending on gestational age and clinical setting.

Perimenopause, Pregnancy, and Hormone Therapy: Sorting Out the Overlap

This area generates significant confusion. Women in perimenopause who start menopausal hormone therapy (MHT) for symptom relief, typically low-dose estradiol plus a progestogen, are not protected from pregnancy by MHT. Standard MHT doses are too low to suppress ovulation.

The HealthRX clinical team uses the following decision framework to help perimenopausal patients sort out their options:

Step 1. Is the patient still having any menstrual bleeding, however irregular? If yes, she is not in confirmed menopause and needs contraception.

Step 2. Does she need vasomotor symptom relief in addition to contraception? If yes, a low-dose COC (20 mcg ethinyl estradiol) addresses both needs for non-smoking women without cardiovascular risk factors.

Step 3. Does she have contraindications to estrogen (VTE history, migraine with aura, active smoking over age 35, hypertension)? If yes, a progestin-only method, copper IUD, or barrier method is preferred.

Step 4. Has she completed 12 consecutive months without bleeding? If yes, contraception may be discontinued and standard MHT dosing can be initiated if symptoms warrant it, with a progestogen added for women with an intact uterus to protect the endometrium.

This framework is not a substitute for individualized clinical assessment. Comorbidities, medication interactions, and patient preferences all influence the final recommendation.

Recognizing Perimenopausal Symptoms Versus Pregnancy Symptoms

Perimenopause and early pregnancy share several symptoms, which can delay recognition of pregnancy in this age group. The overlap includes nausea, breast tenderness, fatigue, mood changes, and missed periods.

Distinguishing features that point toward pregnancy rather than perimenopause:

• A positive urine hCG test. This is the definitive first step. Home tests detect hCG at approximately 20 to 25 mIU/mL, which is reliable from the day of a missed period.
• Rising hCG on serial serum measurements (doubling approximately every 48 to 72 hours in early viable intrauterine pregnancy).
• Transvaginal ultrasound showing a gestational sac.

Women who assume their nausea and missed period are perimenopause without taking a pregnancy test may delay care for weeks. Any missed period in a perimenopausal woman who is sexually active and not using reliable contraception deserves a pregnancy test.

What the Data Say About Unintended Pregnancy in This Age Group

Perimenopausal unintended pregnancy is not rare. The Guttmacher Institute's analysis of CDC data found that women aged 40 to 44 had an unintended pregnancy rate of 35 per 1,000 women per year, higher than the rate for women aged 30 to 34 [13]. The relative rate appears lower than in younger women, but the absolute numbers are substantial because of how many women pass through this life stage.

A notable contributor is contraceptive discontinuation. Women who experience years of infertility in their late 30s, or who simply assume perimenopause means infertility, often stop using contraception before the 12-month amenorrhea threshold is met. Clinician communication about this specific risk at well-woman visits in the 40s is an area where practice consistently falls short.

Talking to Your Clinician: Key Questions to Bring to Your Appointment

Clear, direct questions help patients get actionable answers at gynecology and primary care visits:

• "Based on my bleeding pattern, do I still need contraception?"
• "Which contraceptive method would also help with my hot flashes or heavy bleeding?"
• "If I start hormone therapy for menopause symptoms, does that protect me from pregnancy?"
• "My FSH came back high. Does that mean I can stop using birth control?"
• "How will I know when it is actually safe to stop contraception?"
• "If I got pregnant now, what risks would I face?"

Bringing a list of current medications and a record of your last 6 to 12 menstrual periods (dates and flow characteristics) to the appointment gives the clinician the concrete information needed to individualize recommendations.

The NAMS 2022 Position Statement recommends that "all perimenopausal women should be counseled about the need for contraception until menopause is confirmed by 12 months of amenorrhea," and that this counseling should be repeated proactively rather than waiting for a patient to ask [11].